September 8 2025, David R Brown

Hivest Capital Partners S.A.S., an independent European private equity firm, has entered into an agreement to acquire a stakeholding in Novasol Chemicals, a global distributor of specialty chemicals headquartered in Belgium.

We are proud and excited to support an ambitious management team with a common goal: accelerate the international expansion of Novasol

Barthélemy Grave
Principal at Hivest Capital

Founded in 1997, Novasol has grown into an international chemical distribution platform with operations across Europe, North America and Asia. Novasol distributes specialty chemicals and ingredients to more than 500 clients in over 50 countries, leveraging a broad product portfolio and strong technical expertise across two main verticals: life sciences and material sciences. In recent years, the company has expanded into new geographies, including Turkey and Poland, while strengthening its presence in North America.

Hivest Capital intends to support Novasol's ambitious growth strategy. Together, they aim to accelerate Novasol's international expansion, with a focus on both organic and external growth, further strengthening the company's position in a still fragmented chemical distribution market.

François-Xavier Coiffard, CEO of Novasol: “This partnership with Hivest Capital marks a new chapter in Novasol's growth story. With their support, we will accelerate our international expansion, pursue targeted acquisitions and continue to strengthen our position in high-value markets.”

Annie Okmez, General Manager of Novasol: “Over the past years, Novasol has laid the foundations of a scalable and resilient platform. Together with Hivest Capital, we will seize new opportunities to broaden our product offering, enter new geographies and further strengthen the Group's organization to support our customers worldwide.”

The transaction is subject to customary conditions precedent and regulatory approvals.

About Novasol Chemicals
Novasol Chemicals is a global specialty chemical distributor with a diversified product portfolio across high-value end-markets such as pharmaceuticals, agrochemicals, personal care, CASE & polymers, and energy & environment. With more than 230 suppliers and longstanding blue-chip customer relationships, Novasol has built a reputation for service excellence, regulatory expertise and flexible supply solutions. In 2024, Novasol Chemicals reported revenues of EUR 144M million.

Source(s): Hivest Press Release

Further Information

Visit: https://hivestcapital.com